Case number 2024-2147
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Sep 3, 2024 | 11 | ORDER granting motion to consolidate appeals [10] to the extent that Appeal Nos. 2024-2147 and 2024-2058 are consolidated, and thus one set of briefs should be filed for the appeals, the revised official caption is reflected in this order, and Celltrion's opening brief is due no later than 9/9/2024. The Clerk of Court shall transmit a copy of this order to the merits panel. Service as of this date by the Clerk of Court. [1029427] [24-2147, 24-2058] [NL] [Entered: 09/03/2024 12:23 PM] (2) |
| Sep 3, 2024 | 12 | Note to File: The following cases are consolidated: 24-2058 Lead with 24-2147 as Member case. The parties must file all documents in the lead appeal only. [1029468] [24-2058, 24-2147] [JSP] [Entered: 09/03/2024 02:10 PM] (0) |
| Aug 28, 2024 | 10 | MOTION of Appellant Celltrion, Inc. to consolidate appeals (24-2147 and 24-2058). Service: 08/28/2024 by email. [1028309] [24-2147] [Robert Cerwinski] [Entered: 08/28/2024 10:43 AM] (9) |
| Aug 14, 2024 | 2 | Entry of Appearance for Robert V. Cerwinski; Aviv A. Zalcenstein; Lora M. Green; Michael Johnson; Matthew Freimuth; Jonathan Y. Ellis; Corinne S. Hockman; Michael B. Cottler as counsel for Appellant Celltrion, Inc.. Service: 08/14/2024 by email. [1025072] [24-2147] [Robert Cerwinski] [Entered: 08/14/2024 04:46 PM] (3) |
| Aug 14, 2024 | 3 | Certificate of Interest for Appellant Celltrion, Inc.. Service: 08/14/2024 by email. [1025076] [24-2147] [Robert Cerwinski] [Entered: 08/14/2024 04:48 PM] (4) |
| Aug 14, 2024 | 4 | Notice of Related Case Information for Appellant Celltrion, Inc.. Service: 08/14/2024 by email. [1025080] [24-2147] [Robert Cerwinski] [Entered: 08/14/2024 04:50 PM] (5) |
| Aug 14, 2024 | 5 | Docketing Statement for the Appellant Celltrion, Inc.. Service: 08/14/2024 by email. [1025081] [24-2147] [Robert Cerwinski] [Entered: 08/14/2024 04:51 PM] (2) |
| Aug 14, 2024 | 6 | Entry of Appearance for David I. Berl; Thomas S. Fletcher; Andrew V. Trask; Shaun P. Mahaffy; Kathryn S. Kayali; Arthur J. Argall III; Adam Pan; Christian Gladden-Sorensen; Rhochelle Krawetz; Elizabeth S. Weiswasser; Priyata Patel; Jacob E. Hartman as counsel for Appellee Regeneron Pharmaceuticals, Inc.. Service: 08/14/2024 by email. [1025113] [24-2147] [David Berl] [Entered: 08/14/2024 07:22 PM] (3) |
| Aug 14, 2024 | 7 | Docketing Statement for the Appellee Regeneron Pharmaceuticals, Inc.. Service: 08/14/2024 by email. [1025117] [24-2147] [David Berl] [Entered: 08/14/2024 07:32 PM] (2) |
| Aug 14, 2024 | 8 | Certificate of Interest for Appellee Regeneron Pharmaceuticals, Inc.. Service: 08/14/2024 by email. [1025119] [24-2147] [David Berl] [Entered: 08/14/2024 07:34 PM] (4) |
| Aug 14, 2024 | 9 | Notice of Related Case Information for Appellee Regeneron Pharmaceuticals, Inc.. Service: 08/14/2024 by email. [1025121] [24-2147] [David Berl] [Entered: 08/14/2024 07:37 PM] (4) |
| Jul 31, 2024 | 1 | Appeal docketed. Received: 07/12/2024. [1021726]Entry of Appearance is due on 08/14/2024. Certificate of Interest is due on 08/14/2024. Docketing Statement is due on 08/14/2024. Appellant's brief is due on 09/30/2024. [JSP] [Entered: 07/31/2024 10:55 AM] (78) |
